Institutional Ownership Oric Pharmaceuticals, Inc. (ORIC)
This table provides information about the institutional ownership of Oric Pharmaceuticals, Inc. (ORIC). We have compiled data on the 144 institutions that hold shares in the stock, with a total of 75.4 Million shares, which have been reported (via 13F filing form) to have a value of $359 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Viking Global Investors LP
|
May 15, 2025 Q1 2025 |
6,572,700
shares
|
$31.3 Million
0.12% of portfolio
|
Q1 2025
Added 48.33%
|
|
|
Nextech Invest Ag
|
Feb 14, 2025 Q4 2024 |
5,285,714
shares
|
$25.2 Million
7.95% of portfolio
|
Q1 2024
Added 23.33%
|
|
|
Nextech Invest, Ltd.
Zurich, V8 |
May 15, 2025 Q1 2025 |
5,285,714
shares
|
$25.2 Million
6.85% of portfolio
|
Q1 2025
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,830,880
shares
|
$23 Million
0.0% of portfolio
|
Q2 2024
Added 52.0%
|
|
|
Alkeon Capital Management LLC
New York, NY |
May 14, 2025 Q1 2025 |
4,004,096
shares
|
$19.1 Million
0.05% of portfolio
|
Q1 2025
Added 2.56%
|
|
|
Column Group LLC
San Francisco, CA |
May 14, 2025 Q1 2025 |
3,540,777
shares
|
$16.9 Million
44.68% of portfolio
|
Q1 2024
Reduced 0.77%
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
3,418,068
shares
|
$16.3 Million
1.5% of portfolio
|
Q1 2022
Reduced 1.47%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
3,215,887
shares
|
$15.3 Million
0.0% of portfolio
|
Q1 2025
Added 0.38%
|
|
|
Vr Adviser, LLC
New York, NY |
May 15, 2025 Q1 2025 |
3,182,527
shares
|
$15.1 Million
4.29% of portfolio
|
Q1 2025
Reduced 27.58%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
2,196,549
shares
|
$10.5 Million
0.0% of portfolio
|
Q1 2025
Added 18.97%
|
|
|
Nea Management Company, LLC
Timonium, MD |
May 14, 2025 Q1 2025 |
2,195,545
shares
|
$10.5 Million
1.16% of portfolio
|
Q1 2025
Added 40.19%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
May 12, 2025 Q1 2025 |
2,080,450
shares
|
$9.9 Million
3.15% of portfolio
|
Q1 2025
Added 62.81%
|
|
|
Silverarc Capital Management, LLC
|
May 14, 2025 Q1 2025 |
2,060,240
shares
|
$9.81 Million
2.8% of portfolio
|
Q1 2025
Added 74.85%
|
|
|
First Turn Management, LLC
Del Mar, CA |
May 15, 2025 Q1 2025 |
2,027,430
shares
|
$9.65 Million
2.28% of portfolio
|
Q1 2025
Added 39.72%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
2,007,272
shares
|
$9.55 Million
0.02% of portfolio
|
Q1 2025
Added 29.06%
|
|
|
Commodore Capital LP
New York, NY |
May 15, 2025 Q1 2025 |
2,000,000
shares
|
$9.52 Million
1.09% of portfolio
|
Q1 2024
New holding
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
May 15, 2025 Q1 2025 |
1,410,193
shares
|
$6.71 Million
0.5% of portfolio
|
Q1 2025
Reduced 63.73%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
May 15, 2025 Q1 2025 |
1,399,514
shares
|
$6.66 Million
1.45% of portfolio
|
Q1 2025
New holding
|
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
May 15, 2025 Q1 2025 |
1,346,189
shares
|
$6.41 Million
0.14% of portfolio
|
Q1 2025
Reduced 3.52%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
1,332,860
shares
|
$6.34 Million
0.0% of portfolio
|
Q1 2025
Added 2.92%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
1,305,991
shares
|
$6.22 Million
0.0% of portfolio
|
Q1 2025
Added 2.13%
|
|
|
Franklin Resources Inc
San Mateo, CA |
May 13, 2025 Q1 2025 |
1,022,790
shares
|
$4.87 Million
0.0% of portfolio
|
Q1 2025
Added 7.6%
|
|
|
Siren, L.L.C.
New York, NY |
May 14, 2025 Q1 2025 |
1,007,575
shares
|
$4.8 Million
0.32% of portfolio
|
Q3 2024
New holding
|
|
|
Invus Financial Advisors, LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
1,007,575
shares
|
$4.8 Million
7.98% of portfolio
|
Q4 2020
Reduced -0.0%
|
|
|
Euclidean Capital LLC
New York, NY |
May 15, 2025 Q1 2025 |
989,410
shares
|
$4.71 Million
2.08% of portfolio
|
Q3 2023
Added 32.35%
|